IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bellevue Group AG

Q2 2023 Holdings

Filed 2023-08-14 | 198 holdings | $7.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Intra-Cellular Therapies Inc(ITCIEUR)COM46116X101$202.7M3,201,8002.9%
Neurocrine Biosciences Inc(NBIX)COM64125C109$246.4M2,612,8003.5%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$288.0M842,2244.1%
Argenx SE(ARGX)SPONSORED ADR04016X101$359.8M923,2845.1%
Ionis Pharmaceuticals Inc(IONS)COM462222100$384.9M9,380,3005.5%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$386.1M1,097,1665.5%
PreviousPage 4 of 4